Literature DB >> 9174894

Estimation of the cut-off value in cardiovascular autonomic nervous function tests: not-age-related criteria or the age-related 5th percentile.

R H Straub1, B Lang, K D Palitzsch, J Schölmerich.   

Abstract

The aim of the study was to estimate the cut-off value of cardiovascular tests using not-age-related criteria or the age-related 5th percentile in 165 diabetic patients. The cANP, pANP, and smNP were assessed using previously recommended standardized test procedures. Prevalence of overall definite (borderline) cANP was 35.2% (23.0%) when using the 5th percentile or 16.4% (27.9%) when using not age-related criteria (p for the difference < 0.0001) (p = 0.3205). Prevalence of pANP was 54.0% and of smNP 37.0%. Concerning cANP, the number of test results below the 5th percentile (N5) correlated significantly with the number of abnormal test results using not age-related criteria (Nnar) (p < 0.000001) but the slope of the regression line differed substantially from 1. Using the 5th percentile as the cut-off value for cANP testing, sensitivity and specificity were calculated for not age-related criteria for respiratory sinus arrhythmia (90.5%, 80.2%), Valsalva test (30.4%, 98.0%), lying-to-standing test (46.3%, 98.7%), orthostatic systolic blood pressure fall (69.0%, 78.3%), and overall definite cANP (44.8%, 92.8%). The statistical analysis revealed that the age-related 5th percentile is superior to the not-age-related cut-off values in diabetic patients. We therefore suggest that age-related normal values (percentiles) have to be applied when cANP is estimated.

Entities:  

Mesh:

Year:  1997        PMID: 9174894     DOI: 10.1016/1056-8727(95)00126-3

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  4 in total

1.  [Cardiovascular and pupillary autonomic and somatosensory neuropathy in chronic diseases with autoimmune phenomena. A comparative study of patients with Crohn disease, ulcerative colitis, systemic lupus erythematosus, progressive systemic sclerosis and type I diabetes mellitus].

Authors:  R H Straub; T Andus; G Lock; M Zeuner; K D Palitzsch; V Gross; B Lang; J Schölmerich
Journal:  Med Klin (Munich)       Date:  1997-11-15

2.  Autonomic testing in healthy subjects: preliminary observations.

Authors:  Gisela Chelimsky; Sarah Ialacci; Thomas C Chelimsky
Journal:  Clin Auton Res       Date:  2012-10-30       Impact factor: 4.435

3.  Diagnostic performance analysis for diabetic cardiovascular autonomic neuropathy based on short-term heart rate variability using Bayesian methods: preliminary analysis.

Authors:  Jun Chen; Shuang-Bin Yang; Juanmei Liu; Zi-Hui Tang
Journal:  Diabetol Metab Syndr       Date:  2015-09-10       Impact factor: 3.320

4.  Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short-term heart rate variability without a gold standard.

Authors:  Zi-Hui Tang; Lin Wang; Fangfang Zeng; Zhongtao Li; Xiaoling Yu; Keqin Zhang; Linuo Zhou
Journal:  BMJ Open       Date:  2014-10-06       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.